Search Results

Site Search

Testing Archives - Page 24 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

5 Steps to Improve Communication in Laboratory Outreach - Insights

Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.

Testing Archives - Page 9 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Neuropathy and Neuromuscular Gene Panel Update - Insights

In this month's "Hot Topic," Christopher Klein, M.D., and Zhiyv (Neal) Niu, Ph.D., discuss how Mayo Clinic’s neuropathy and neuromuscular gene panels have enhanced patient care.

MCL GATA2 Gene Sequencing Patient Information MC1235249

MCL GATA2 Gene Sequencing Patient Information Complete print GATA2 Gene Sequencing Patient Information Reset Form Instructions accurate interpretation reporting genetic results

Test Utilization Practices for Venous Thromboembolism: A Model of Cost Savings and Efficiency at Mayo Clinic - Insights

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.

MCL @Work: Rachel Freeman - Insights

Rachel is a referral specialist serving as the important link between Mayo Clinic Laboratories and our clients. With an eye on quality assurance, she helps patients and clinicians get answers faster.

MCL @Work: Annette Bjorheim - Insights

As supervisor of the Tissue Registry Archive, Annette Bjorheim finds purpose in her work to provide archived material for patient testing, education, and research needs.

MCL @Work: Spencer Beekmann - Insights

As a field service coordinator at Mayo Clinic Laboratories, Spencer Beekmann spends much of his time onboarding and training new staff on the Client Site Specimen Processing and Regional Service Representative teams. After seven years at...

Cytology: A compelling molecular testing approach - Insights

Learn more about how Mayo Clinic Laboratories is advancing the use of cytology specimens for solid tumor next-generation sequencing.